Contract: InBios, $12.7M

InBios International Inc., Seattle, Wash., has been awarded a $12,670,301 firm-fixed-price contract for expansion of production capability for COVID-19 Rapid test. This contract provides for expansion of production capability for the SCoV-2 IgG/IgM Detect and SCoV-2 Ag Detect tests. Work will be performed in Seattle and is expected to be completed by April 2021. This award is the result of a competitive acquisition. Funding is authorized through Health Care Enhancement Act (H.R. 266) from the Biomedical Advanced Research and Development Authority and funds in the full amount will be obligated at the time of award. The Air Force Life Cycle Management Center, Eglin Air Force Base, Fla., is the contracting activity (FA8656-21-C-8877). (Source: DoD, 10/30/20)